--- title: "iTonic Holdings Ltd. (ITOC.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ITOC.US.md" symbol: "ITOC.US" name: "iTonic Holdings Ltd." industry: "Health Care Technology" datetime: "2026-05-21T14:01:14.787Z" locales: - [en](https://longbridge.com/en/quote/ITOC.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ITOC.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ITOC.US.md) --- # iTonic Holdings Ltd. (ITOC.US) ## Company Overview iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company’s proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. | Item | Detail | |------|--------| | Industry | Health Care Technology | | Exchange | US Market | | Website | [www.ftzy.com.cn](https://www.ftzy.com.cn) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: C > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-21T04:30:16.000Z **Overall: C (0.50)** **Industry**: Health Care Technology | Metric | Value | |--------|-------| | Industry Ranking | 29 / 47 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: C #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.70% | | | Net Profit YoY | -671.72% | | | P/B Ratio | 0.80 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 4908695.00 | | | Revenue | 523031.00 | | #### Multi Score Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -82.84% | E | | Profit Margin | -974.68% | E | | Gross Margin | 62.59% | A | | Revenue YoY | 16.70% | B | | Net Profit YoY | -671.72% | E | | Total Assets YoY | 35.30% | A | | Net Assets YoY | 31.40% | A | | Cash Flow Margin | 63.39% | C | | OCF YoY | 16.70% | B | | Turnover | 0.07 | E | | Gearing Ratio | 10.66% | A | ```chart-data:radar { "title": "Longbridge Financial Score - iTonic Holdings Ltd.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "16.70%", "rating": "" }, { "name": "Net Profit YoY", "value": "-671.72%", "rating": "" }, { "name": "P/B Ratio", "value": "0.80", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "4908695.00", "rating": "" }, { "name": "Revenue", "value": "523031.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "C", "indicators": [ { "name": "ROE", "value": "-82.84%", "rating": "E" }, { "name": "Profit Margin", "value": "-974.68%", "rating": "E" }, { "name": "Gross Margin", "value": "62.59%", "rating": "A" }, { "name": "Revenue YoY", "value": "16.70%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-671.72%", "rating": "E" }, { "name": "Total Assets YoY", "value": "35.30%", "rating": "A" }, { "name": "Net Assets YoY", "value": "31.40%", "rating": "A" }, { "name": "Cash Flow Margin", "value": "63.39%", "rating": "C" }, { "name": "OCF YoY", "value": "16.70%", "rating": "B" }, { "name": "Turnover", "value": "0.07", "rating": "E" }, { "name": "Gearing Ratio", "value": "10.66%", "rating": "A" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.96 | 23/47 | - | - | - | | PB | 0.80 | 9/47 | 1.48 | 1.15 | 0.87 | | PS (TTM) | 9.39 | 30/47 | 22.98 | 17.84 | 10.14 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | QHSLab, Inc. (USAQ.US) | A | A | A | A | C | A | | 02 | Veeva Systems -CL (VEEV.US) | A | B | C | A | B | B | | 03 | Waystar (WAY.US) | B | A | D | B | B | B | | 04 | Doximity (DOCS.US) | A | C | C | A | B | B | | 05 | HeartFlow (HTFL.US) | B | A | B | A | B | B | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ITOC.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ITOC.US/norm.md) - [Related News](https://longbridge.com/en/quote/ITOC.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ITOC.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**